Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) Short Interest Update

Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) was the recipient of a large decline in short interest in the month of February. As of February 27th, there was short interest totaling 2,676 shares, a decline of 85.0% from the February 12th total of 17,842 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 54,285 shares, the short-interest ratio is presently 0.0 days. Based on an average daily trading volume, of 54,285 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company’s shares are sold short.

Hong Kong Pharma Digital Technology Stock Performance

Shares of HKPD stock traded up $0.01 during trading on Thursday, hitting $0.64. 3,864 shares of the company were exchanged, compared to its average volume of 41,992. The business’s 50-day simple moving average is $0.76 and its 200 day simple moving average is $1.02. Hong Kong Pharma Digital Technology has a twelve month low of $0.60 and a twelve month high of $2.76.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Hong Kong Pharma Digital Technology in a research note on Friday, January 9th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

Institutional Trading of Hong Kong Pharma Digital Technology

A hedge fund recently bought a new stake in Hong Kong Pharma Digital Technology stock. StoneX Group Inc. acquired a new stake in shares of Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 43,284 shares of the company’s stock, valued at approximately $36,000. StoneX Group Inc. owned about 0.39% of Hong Kong Pharma Digital Technology at the end of the most recent quarter.

Hong Kong Pharma Digital Technology Company Profile

Hong Kong Pharma is an exempted limited liability company formed under the laws of the Cayman Islands on August 17, 2023. As a holding company with no material operations of its own, Hong Kong Pharma conducts its operations through its wholly owned subsidiaries, Joint Cross Border Logistics Company Limited and V-Alliance Technology Supplies Limited, each a limited liability corporation incorporated in Hong Kong and collectively referred to as HK Subsidiaries. Our business offering consists of two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, primarily conducted through our Hong Kong subsidiary, Joint Cross Border, which we refer to as the “Supply Chain Services” division and (ii) OTC pharmaceutical cross-border procurement and distribution, primarily conducted through our Hong Kong subsidiary, V-Alliance, which we refer to as the “Procurement and Distribution” division.